Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-19
    E.g., 2018-08-19

Archive Search

4 results
12:00 AM, Apr 20, 2015  |  BC Week In Review | Company News  |  Deals

Can-Fite, Cipher deal

finished product to Cipher. Cipher said it sees CF101 as being complementary to the company’s Beteflam Patch
12:00 AM, Mar 16, 2015  |  BC Week In Review | Clinical News  |  Regulatory

Beteflam Patch regulatory update

Health Canada accepted for review an NDS for Beteflam Patch from Cipher Pharmaceuticals Inc. (TSX:CPH; NASDAQ:CPHR, Mississauga …
deal granting Cipher marketing rights to the product in Canada (see BioCentury, Aug. 13, 2012). Beteflam Patch
self-adhesive medicated plaster containing 0.1% betamethasone valerate. Institut Biochimique S.A. , Lugano, Switzerland   Product: Beteflam Patch
12:00 AM, Oct 01, 2012  |  BioCentury | Finance

3Q Stock Wrap-Up: Back in black

active rheumatoid arthritis (RA) Submit MAA and BLA 4Q12 Cipher Pharmaceuticals Inc. (TSX:DND)/Institut Biochimique S.A. Betesil Patch
12:00 AM, Aug 13, 2012  |  BC Week In Review | Company News  |  Sales & Marketing

Cipher, Institut Biochimique sales and marketing update

Cipher received exclusive Canadian rights to market Institut's Betesil Patch to treat inflammatory skin conditions, including plaque …